News

inprother_logo_fa7268
inprother_funding_thumb
Inprother_Jordi_Naval_CEO
_DSC2407final
InProTher_Sharon_Glynn
inprotherblogpost
inprotherblog
bloginprotherpost
inprother-blogpost
SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)
team
biotech
DEMODAY
STEVENGLAZER
peter-johannes-holst
Blog_post_1
Blog_post_2